Authors
Loading...
Clinical trial demonstrates gene expression profiles in PBMCs predict relapse in dogs with DLBCL, suggesting immune signatures influence outcomes.
Rao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: